Loading clinical trials...
Loading clinical trials...
Interest of Systematic PPI Therapy After POEM vs Symptomatic Use of PPI Therapy in Prevention of Gastroesophageal Reflux Disease After POEM for Esophageal Achalasia. A Comparative Retrospective Analysis.
Conditions
Locations
1
France
Uhmontpellier
Montpellier, France
Start Date
January 1, 2017
Primary Completion Date
January 1, 2022
Completion Date
March 31, 2022
Last Updated
February 5, 2021
NCT05556824
NCT04641702
NCT06883175
NCT05132816
NCT00590239
NCT06213662
Lead Sponsor
University Hospital, Montpellier
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions